Form 4 for GEHC GE HealthCare
Accepted 2023-01-05 00:00:00 ET · period of report 2023-01-03 · accession 0000899243-23-001111 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2023-01-05 | 2023-01-03 | GEHC | O'Neill Kevin Michael | CEO, PDx | A - Grant | — | +59 | 59 | New | — |
| DM | 2023-01-05 | 2023-01-04 | GEHC | O'Neill Kevin Michael | CEO, PDx | A - Grant | — | +76.1K | 3,329 | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, par value $0.01 per share | 2023-01-03 | A | A | 59 | — | 59 | I By share incentive plan trust | — | — | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 5,877 | — | 5,877 | D | $99.21 · — to 2027-11-17 | 5,877 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 3 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 4,592 | — | 4,592 | D | $76.66 · — to 2028-03-19 | 4,592 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 4 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 13,275 | — | 13,275 | D | $40.40 · — to 2028-12-21 | 13,275 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 5 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 3,106 | — | 3,106 | D | $57.74 · — to 2029-03-19 | 3,106 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 6 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 1,614 | — | 1,614 | D | $51.67 · — to 2029-04-11 | 1,614 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 7 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 10,820 | — | 10,820 | D | $63.51 · — to 2030-03-02 | 10,820 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F3) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% is fully exercisable immediately and 50% will become exercisable on March 2, 2023. |
| 8 | Derivative | Restricted Stock Units | 2023-01-04 | A | A | 1,622 | — | 1,622 | D | — · — to — | 1,622 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F4) Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. (F5) Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023. |
| 9 | Derivative | Restricted Stock Units | 2023-01-04 | A | A | 6,519 | — | 6,519 | D | — · — to — | 6,519 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F4) Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. (F6) Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on August 3, 2023 and 50% will vest on August 3, 2024. |
| 10 | Derivative | Restricted Stock Units | 2023-01-04 | A | A | 5,568 | — | 5,568 | D | — · — to — | 5,568 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F4) Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. (F7) Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024. |
| 11 | Derivative | Restricted Stock Units | 2023-01-04 | A | A | 9,106 | — | 9,106 | D | — · — to — | 9,106 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F4) Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. (F8) Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025. |
| 12 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 1,653 | — | 1,653 | D | $129.52 · — to 2023-09-13 | 1,653 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 13 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 5,051 | — | 5,051 | D | $161.30 · — to 2026-09-30 | 5,051 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 14 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 3,672 | — | 3,672 | D | $135.92 · — to 2025-09-11 | 3,672 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 15 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 343 | — | 343 | D | $142.15 · — to 2024-09-05 | 343 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |
| 16 | Derivative | Employee Stock Option (right to buy) | 2023-01-04 | A | A | 3,329 | — | 3,329 | D | $142.15 · — to 2024-09-05 | 3,329 Common stock, par value $0.01 per share | (F1) The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. (F2) Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately. |